News | September 12, 2023
Indian pharma industry to witness 8-10% revenue growth in fiscal 2024: CRISIL
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
The generous donation includes multiple medical equipments
Marking a significant milestone in its commitment to holistic wellness
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
These plant locations include Ramagundam, Talcher Kaniha, Korba, Vindhyachal, Dadri, Barh, Solapur, North Karanpura, and Mauda
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
Subscribe To Our Newsletter & Stay Updated
